NCT02987686View on ClinicalTrials.gov

Topical Infliximab for Sterile Corneal Melt

PHASE1RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 6, 2017

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2027

Conditions
Sterile Corneal Melt
Interventions
DRUG

Topical Infliximab

Aside from the standard treatment, patients will receive topical infliximab ( 10mg/ml) four (4) time per day for four (4) weeks.

Trial Locations (1)

H2X3E4

RECRUITING

Centre Hospitalier de l'Université de Montréal, Montreal

All Listed Sponsors
collaborator

Fonds de recherche en ophtalmologie de l'Université de Montréal

OTHER

lead

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER